首页> 美国卫生研究院文献>other >Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated hospital-acquired bacterial infections
【2h】

Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated hospital-acquired bacterial infections

机译:重新使用烟酰胺作为通用的抗菌表面涂层以抵抗与设备相关的医院获得性细菌感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Device-associated and hospital-acquired infections remain amongst the greatest challenges in regenerative medicine. Furthermore, the rapid emergence of antibiotic resistance and lack of new classes of antibiotics has made the treatment of these bacterial infections increasingly difficult. The repurposing of Food and Drug Administration (FDA) approved drugs for antimicrobial therapies is a powerful means of reducing the time and cost associated with drug discovery and development. In this work, niclosamide, a commercially available anthelmintic drug with recently identified antimicrobial properties, was found to prevent and combat existing biofilms of several relevant Gram-positive bacteria, namely strains of Staphylococcus aureus, including methicillin resistant S. aureus (MRSA), and Staphylococcus epidermidis, all common causes of hospital-acquired and device-associated infections. This anti-biofilm activity was demonstrated at niclosamide concentrations as low as 0.01 μg/mL. We then assessed niclosamide activity as an antibacterial coating, which could potentially be applied to medical device surfaces. We developed solvent cast niclosamide coatings on a variety of surfaces common amongst medical devices including glass, titanium, stainless steel, and aluminum. Niclosamide-coated surfaces exhibited potent in vitro activity against S. aureus, MRSA, and S. epidermidis. At niclosamide surface concentrations as low as 1.6 × 10−2 μg/mm2, the coatings prevented attachment of these bacteria. The coatings also cleared bacteria inoculated suspensions at niclosamide surface concentrations of 3.1 × 10−2 μg/mm2. Hemolysis was not observed at any of the antimicrobial coating concentrations tested. We report a facile, effective means of coating devices with niclosamide to both clear and prevent biofilm formation of common bacteria encountered in hospital-acquired and device-associated infections.
机译:设备相关的感染和医院获得的感染仍然是再生医学面临的最大挑战之一。此外,抗生素抗性的迅速出现和新型抗生素的缺乏使这些细菌感染的治疗越来越困难。重新使用美国食品药品管理局(FDA)批准的抗微生物药物,是减少与药物研发相关的时间和成本的有力手段。在这项工作中,发现了具有新近鉴定的抗菌特性的市售驱虫药烟酰胺,它可以预防和对抗几种相关的革兰氏阳性细菌的现有生物膜,包括金黄色葡萄球菌菌株,包括耐甲氧西林金黄色葡萄球菌(MRSA),以及表皮葡萄球菌是医院获得性感染和器械相关感染的所有常见原因。在低至0.01μg/ mL的烟酰胺浓度下证明了这种抗生物膜活性。然后,我们评估了尼克洛酰胺作为抗菌涂层的活性,该涂层可能会应用于医疗器械表面。我们在包括玻璃,钛,不锈钢和铝在内的医疗设备中常见的各种表面上开发了溶剂浇铸烟酰胺涂层。 Niclosamide涂层表面表现出有效的抗金黄色葡萄球菌,MRSA和表皮葡萄球菌的体外活性。在烟酰胺表面浓度低至1.6×10 −2 μg/ mm 2 时,涂层阻止了这些细菌的附着。该涂层还清除了浓度为3.1×10 -2 μg/ mm 2 的烟酰胺表面浓度的细菌接种悬浮液。在任何测试的抗菌涂层浓度下均未观察到溶血。我们报告了一种简便,有效的方法,用尼克洛酰胺包被器械可以清除和防止医院获得的和与器械相关的感染中常见细菌的生物膜形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号